This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effect of omega 3 FA supplementation on cognitive functions in patients with dementia or mild cognitive impairment.
To assess the effect of omega 3 FA on global disease severity, neuropsychiatric symptoms, quality of life and performance of activities of daily living (ADLs) and to assess the safety and acceptability of omega 3 FA supplementation in patients with dementia and mild cognitive impairment.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.